Products 17008-65-0

CAS 17008-65-0 appears in our catalog under these names: Bufarenogin/ 98.77% (existing batch purity), Bufarenogin, Bufarenogin, 99.36%, Bufarenogin, ≥98%. Offered by: TargetMol, Biosynth, MedChemExpress, Chemat. Available pack sizes: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 10 mg, 5 mg.

Bufarenogin/ 98.77% (existing batch purity)
TargetMol
  • size: 1mg, 2mg, 5mg, 10mg
  • Variants: 5
from 651.67
View product
Bufarenogin
Biosynth, Chemat
  • size: 10mg, 25mg, 50mg, 1mg
  • Variants: 9
from 438.80
View product
Bufarenogin, 99.36%
MedChemExpress
  • size: 10 mg, 5 mg
  • Variants: 2
from 1225.27
View product
Bufarenogin, ≥98%
Chemat
  • size: 5mg, 10mg
  • Variants: 2
from 1019.60
View product
Structural formula: {0} (CAS {1})

5-[(3S,5R,8R,9S,10S,12S,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one (CAS 17008-65-0) is a chemical compound with the molecular formula C24H32O6 and a molecular weight of 416.5 g/mol. IUPAC name: 5-[(3S,5R,8R,9S,10S,12S,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one. InChIKey: SOGONHOGEFLVPE-PUVOGLICSA-N.

Identity
Molecular formulaC24H32O6
Molecular weight416.5 g/mol
IUPAC name5-[(3S,5R,8R,9S,10S,12S,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one
InChIKeySOGONHOGEFLVPE-PUVOGLICSA-N
SMILESC[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C(=O)[C@H]([C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O)O

Computed by PubChem (NCBI)

Synonyms: Bufarenogin, 3beta,12beta,14-Trihydroxy-11-oxo-5beta-bufa-20,22-dienolide, Bufa-20,22-dienolide, 3,12,14-trihydroxy-11-oxo-, (3beta,5beta,12beta)-, Bufarenogen, orb1297437, 3,12,14-Trihydroxy-11-oxobufa-20,22-dienolide, 3|A,12|A,14-Trihydroxy-11-oxo-5|A-bufa-20,22-dienolide, 11-oxo-3beta,12beta,14beta-trihydroxy-5beta-bufa-20,22-dienolide, 5beta-Bufa-20,22-dienolide, 3beta,12beta,14-trihydroxy-11-oxo-, (3beta,5beta,12beta)-3,12,14-Trihydroxy-11-oxobufa-20,22-dienolide
Related forms of this compound
5-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3,12,14-trihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one C24H32O6
Isomers (same molecular formula)
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C24H32O6
methyl (7R,8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate C24H32O6
(1S,2S,4R,8S,9S,11S,12S,13S,14R,18R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxahexacyclo[10.8.0.02,9.04,8.013,18.014,18]icos-16-en-15-one C24H32O6
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-9,13-dimethyl-16-oxo-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-8-carboxylic acid C24H32O6
[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C24H32O6
(1S,2S,4R,8S,9S,11R,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one C24H32O6
methyl (7S,8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate C24H32O6
[2-[(6R,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C24H32O6
117895-92-8 C24H32O6
3386-78-5 C24H32O6
[2-[(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C24H32O6